Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders

There are divergent views on the potential of real-world data (RWD) to inform decisions made by regulators, health technology assessment (HTA) bodies, payers, clinicians, and patients. This RWE4Decisions initiative explored the particularly challenging setting of highly innovative technologies, whic...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	International journal of technology assessment in health care Ročník 36; číslo 4; s. 459 - 468
Hlavní autoři:	Facey, Karen M., Rannanheimo, Piia, Batchelor, Laura, Borchardt, Marine, de Cock, Jo
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	New York, USA Cambridge University Press 01.08.2020
Témata:	Case studies Collaboration Decision analysis Decision making Disease Initiatives Learning Life cycles Meetings Pharmaceutical industry Policy Rare diseases Regulators Regulatory approval Reimbursement Stakeholders Task forces Technology Technology assessment Workshops United States > US Decision making Reimbursement mechanisms Real-world data Stakeholder participation Real-world evidence
ISSN:	0266-4623, 1471-6348, 1471-6348
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!